Skip to main content
Georgia Public Broadcasting Logo
  • TV

    Featured Specials and Programs

    • All Creatures Great and Small
    • Miss Scarlet & The Duke
    • Antiques Roadshow
    • PBS Newshour
    • Finding Your Roots
    • The U.S. and the Holocaust
    All Programs

    GPB Originals

    • Georgia Outdoors
    • View Finders
    • A Fork in the Road
    • The Steeple
    • Lawmakers
    • Football Fridays in Georgia
    GPB Originals

    Browse by Genre

    • Arts & Music
    • Culture
    • Drama
    • Food
    • History
    • News & Public Affairs
    • TV Schedule
    • GPB Programs
    • PBS Passport
    • TV Highlights this Week
    • PBS KIDS
    • Ways to Watch
    • Newsletters
    • Contact GPB
  • Radio

    Featured Programs

    • Political Rewind
    • The Daily
    • Morning Edition
    • All Things Considered
    • Serendipity
    • John Lemley's City Cafe
    • Fresh Air
    • Here and Now
    • Code Switch/Life Kit
    • Wait Wait... Don't Tell Me!
    All Programs

    Podcasts

    • GA Today
    • Salvation South
    • Battleground: Ballot Box
    • Football Fridays in Georgia
    • Classroom Conversations
    • Radio Schedule
    • GPB Classical
    • Radio Programs
    • Podcasts
    • GPB News
    • Find Your Station
    • Contact GPB
    • Newsletters
  • News

    Featured Programs & Series

    • Political Rewind
    • Lawmakers
    • Lawmakers: Beyond the Dome
    • 1A
    • Battleground: Ballot Box
    • GA Today Podcast
    • Storycorps
    • Powering Georgia
    • Food Access

    More GPB News

    • Politics
    • Georgia News
    • Justice
    • Arts & Life
    • Health
    All GPB News
    • Radio Schedule
    • Radio Stations
    • GPB Apps
    • Contact GPB News
    • Follow Us on Apple News
    • Newsletters
  • Education

    Browse by Subject

    • CTAE
    • English Language Arts
    • Mathematics
    • Physical Health and Wellness
    • Professional Learning
    • STEAM
    • Science
    • Social Studies
    • The Arts
    • World Languages

    Browse by Grade

    • Preschool-PreK
    • K-2
    • 3-5
    • 6-8
    • 9-12

    Featured

    • Classroom Conversations Podcast
    • Georgia Studies Collection
    • Econ Express
    • VR in the Classroom
    • Lights, Camera, Budget!
    • Georgia Home Classroom
    • Chemistry Matters
    • Physics in Motion
    • Virtual Field Trips
    • Writers Contest
    • PBS LearningMedia
    • PBS KIDS
  • Sports

    GHSA Sports

    • Football
    • Basketball
    • Cheerleading
    • On Demand
    • GPB Sports Blog
    All Sports

    High School Football

    • Scores & Schedule
    • On Demand
    • Teams
    • Rankings
    • Brackets
    • Champions
    • Buckle Up Georgia
    Football Home
    • GPB Sports App
    • GPB Sports Blog
    • GPB Sports OnDemand
  • Events

    Browse by Type

    • Community
    • Donor
    • Kids & Family
    • Screenings
    All Events

    Browse by Category

    • Education
    • News
    • Sports
    • Television

    Sign up to receive GPB Event announcements via Email.

    Sign up

    • on Twitter
    • on Facebook
    • on Instagram
  • Kids & Family

    For Kids

    • Video
    • Games

    For Parents & Caregivers

    • Kids & Family Blog
    • Kids & Family Events
    • GPB KIDS - Ways to Watch
  • Support Us

    Support GPB

    • Ways to Give
    • Planned Giving
    • Sustainers
    • GPB Passport
    • Leadership Giving
    • Corporate Sponsorship
    • Vehicle Donations
    • GPB Next
    • Matching Gifts
  • Search
GPB Passport icon GPB Passport icon Passport
GPB donate icon GPB donate icon Donate
Listen Live Listen Live Watch Live Watch Live
GPB News

GPB Newsletter CTA

Sign Up For Our Newsletter

News Topics

  • Georgia
  • National
  • Election
  • Lawmakers
  • Battleground: Ballot Box

Don't Miss

Don't Miss:

  • Watch: GPB's Lawmakers
  • TV Highlights This Week
  • GA Today daily podcast

News Articles: COVID treatments

Starting May 11 most people will have to pay for those at-home test kits for COVID-19, as the federal government's declaration of a COVID-19 public health emergency officially ends.

Tagged as: 

  • Health

COVID test kits, treatments and vaccines won't be free to many consumers much longer

Insurers, employers, taxpayers and other consumers will all be affected as drugmakers move these products to the commercial market in May. How much you'll pay depends on your health insurance.

February 08, 2023
|
By:
  • Julie Appleby
Pfizer's Paxlovid pills are considered the most effective treatment to prevent severe COVID. They're about to be sold in China. But they are reportedly underused in the U.S.

Tagged as: 

  • Global Health

Coronavirus FAQ: Is Paxlovid the best treatment? Is it underused in the U.S.?

The drug is the most effective way to cut the risk of severe disease. It's heading to China now. Yet the drug is underused in some places. Why? And are there options if you're not a good candidate?

December 16, 2022
|
By:
  • Fran Kritz
Antonio Rapuano got an infusion of a monoclonal antibody to treat his COVID in Albano, Italy in 2021. Such infusions have been effective treatments for COVID during the pandemic, but doctors are now finding that most monoclonal antibodies no longer work against new variants of SARS-CoV-2.

Tagged as: 

  • Health

How monoclonal antibodies lost the fight with new COVID variants

The treatments were highly popular earlier in the pandemic. One by one, they got knocked out by more convenient, less expensive treatment options, and new COVID variants.

November 21, 2022
|
By:
  • Pien Huang
TK

Tagged as: 

  • Health

3 ways to get COVID pills, if you've just tested positive

Some people have had trouble getting Paxlovid pills quickly, despite the administration's effort to ease access after a COVID test confirms infection.

May 11, 2022
|
By:
  • Pien Huang
Treatments like monoclonal antibody infusions and antiviral pills can prevent a case of COVID-19 from becoming life-threatening. But many of the available drugs are not being used.

Tagged as: 

  • Health

Lifesaving COVID drugs are sitting unused on pharmacy shelves, HHS data shows

States and health providers report they've dispensed less than half their supply from the government, raising fears that the drugs may go to waste while people who could benefit get sicker.

March 18, 2022
|
By:
  • Pien Huang
Paxlovid tablets are packaged at a Pfizer factory in Italy.

Tagged as: 

  • Health

Feds' contract with Pfizer for Paxlovid has some surprises

NPR has obtained the government's $5.3 billion contract for the first 10 million courses of Paxlovid, an antiviral pill for COVID-19. Here's what's in it.

February 02, 2022
|
By:
  • Sydney Lupkin
Evusheld is a treatment authorized for prevention of COVID-19 in people who are seriously immunocompromised or who have had serious adverse reactions to COVID-19 vaccines.

Tagged as: 

  • Health

Hospitals use a lottery to allocate scarce COVID drugs for the immunocompromised

So far the government has distributed about 300,000 doses of Evusheld, a new drug that protects against COVID-19. Some 7 million Americans could benefit from the drug right away.

January 25, 2022
|
By:
  • Pien Huang

Tagged as: 

  • Health

The COVID antiviral drugs are here but they're scarce. Here's what to know

Paxlovid and molnupiravir have been authorized for emergency use to keep COVID-19 patients out of the hospital, but don't expect to be able to go to your usual pharmacy and get them.

December 31, 2021
|
By:
  • Sydney Lupkin
Pfizer's antiviral pill Paxlovid was authorized to treat COVID-19, by the Food and Drug Administration on Wednesday.

Tagged as: 

  • Health

FDA authorizes 1st antiviral pill for COVID

In a highly anticipated decision, the Food and Drug Administration authorized Pfizer's Paxlovid as the first antiviral pill to treat COVID-19 at home.

December 22, 2021
|
By:
  • Scott Hensley
Molnupiravir, an antiviral drug to treat mild to moderate COVID-19, is under consideration by an FDA advisory panel for possible authorization.

Tagged as: 

  • Health

New antiviral drugs are coming for COVID. Here's what you need to know

The FDA is considering new pills that could treat people in early stages of COVID. Here's what to know about how they work, how effective they are and the impact they could make on the pandemic.

November 30, 2021
|
By:
  • Pien Huang
A nurse walks into a tent clinic

Tagged as: 

  • Health

This North Georgia City Offers A Clinic For Early COVID-19 Treatment — And It's Free

Dalton’s new Regeneron treatment drive-in clinic helped about 60 people receive Regeneron’s monoclonal antibody treatment for early diagnosed COVID-19 cases. The city council believes this clinic is the first of its kind in Georgia.

September 02, 2021
|
By:
  • Ellen Eldridge
Jennifer Minhas had been a nurse for years when she contracted COVID-19 in 2020. Since then, lingering symptoms — what's known as long-haul COVID-19 — made it impossible for her to work. For months, she and her doctors struggled to understand what was behind her fatigue and rapid heartbeat, among other symptoms.

Tagged as: 

  • Health

After Months Of A Racing Heart And Burning Feet, A COVID Long-Hauler Gets A Diagnosis

Jennifer Minhas is among those who suffer lingering problems after COVID-19. A diagnosis of POTS, a little-known circulation disorder that mostly affects women, offers a way forward.

May 22, 2021
|
By:
  • Allison Aubrey
Deaths from COVID-19 are often due to the immune system overreacting to the coronavirus. New drugs to suppress that reaction are showing promise, say researchers.

Tagged as: 

  • Health

Drugs Targeting Immune Response To COVID-19 Show Promise

Researchers are reporting some progress in their search for drugs that tamp down the overwhelming immune reaction that can kill a patient with COVID-19.

April 07, 2021
|
By:
  • Richard Harris
Nurse Janet Gilleran prepares to treat COVID-19 patient Mike Mokler with bamlanivimab, a monoclonal antibody drug from Eli Lilly, at the Respiratory Infection Clinic of Tufts Medical Center in Boston on Dec. 31, 2020.

Tagged as: 

  • Health

Doctors Encouraged By Antibody Treatments For COVID-19

While logistical challenges have hampered use of antibody drugs to treat people with mild-to-moderate COVID-19, recent results show the medicines can be worthwhile.

January 06, 2021
|
By:
  • Richard Harris
This April 26, 2017, file photo shows the Eli Lilly & Co. corporate headquarters in Indianapolis.

Tagged as: 

  • Health

FDA Allows Emergency Use Of First COVID-19 Antibody Drug

U.S. health officials have allowed emergency use of the first antibody drug to help the immune system fight COVID-19.

November 09, 2020
|
By:
  • Associated Press
  • Load More

Newsletter Signup

Sign Up For Our Newsletters

Connect with GPB

  • Connect with GPB on Facebook
  • Connect with GPB on Instagram
  • Connect with GPB on Twitter
  • Connect with GPB on YouTube
  • Connect with GPB on Apple News

Footer

Footer First Nav (Main Menu)

  • TV
  • Radio
  • News
  • Education
  • Sports
  • Events
  • Kids & Family
  • Support Us
  • Search

Footer Second Nav Menu

  • Help Center
  • About GPB
  • Contact Us
  • Closed Captioning
  • Directions
  • Studio Production
  • Program Submissions

Footer Third Nav Menu

  • Support Us
  • Careers
  • Accessibility
  • FCC Public Files
  • Drawing Rules
  • News Media Request
  • Open Records Policy
  • Privacy Policy

Georgia Public Broadcasting

260 14th St. NW
Atlanta, GA 30318
United States

(404) 685-2400 In Atlanta
(800) 222-4788 Outside Atlanta
ask@gpb.org

Newsletter Signup

Sign Up For Our Newsletters

Connect with GPB

  • Connect with GPB on Facebook
  • Connect with GPB on Instagram
  • Connect with GPB on Twitter
  • Connect with GPB on YouTube
  • Connect with GPB on Apple News
© Copyright 2023, Georgia Public Broadcasting. All Rights Reserved. Georgia Public Radio® GPTV®